190 related articles for article (PubMed ID: 9747871)
1. Potentiation of lonidamine and diazepam, two agents acting on mitochondria, in human glioblastoma treatment.
Miccoli L; Poirson-Bichat F; Sureau F; Bras Gonçalves R; Bourgeois Y; Dutrillaux B; Poupon MF; Oudard S
J Natl Cancer Inst; 1998 Sep; 90(18):1400-6. PubMed ID: 9747871
[TBL] [Abstract][Full Text] [Related]
2. [Targeting the gene of glucose metabolism for the treatment of advanced gliomas].
Oudard S; Miccoli L; Dutrillaux B; Poupon MF
Bull Cancer; 1998 Jul; 85(7):622-6. PubMed ID: 9752269
[TBL] [Abstract][Full Text] [Related]
3. Effect of lonidamine on the utilization of 14C-labeled glucose by human astrocytoma cells.
Paggi MG; Zupi G; Fanciulli M; Del Carlo C; Giorno S; Laudonio N; Silvestrini B; Caputo A; Floridi A
Exp Mol Pathol; 1987 Oct; 47(2):154-65. PubMed ID: 2820786
[TBL] [Abstract][Full Text] [Related]
4. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
Teicher BA; Herman TS; Holden SA; Epelbaum R; Liu SD; Frei E
Cancer Res; 1991 Feb; 51(3):780-4. PubMed ID: 1988117
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme.
Oudard S; Carpentier A; Banu E; Fauchon F; Celerier D; Poupon MF; Dutrillaux B; Andrieu JM; Delattre JY
J Neurooncol; 2003 May; 63(1):81-6. PubMed ID: 12814259
[TBL] [Abstract][Full Text] [Related]
6. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory action of the antitumor agent lonidamine on mitochondrial respiration of Trypanosoma cruzi and T. brucei.
Turrens JF
Mol Biochem Parasitol; 1986 Sep; 20(3):237-41. PubMed ID: 3531848
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
[TBL] [Abstract][Full Text] [Related]
9. Effect of the antitumor drug lonidamine on glucose metabolism of adriamycin-sensitive and -resistant human breast cancer cells.
Fanciulli M; Valentini A; Bruno T; Citro G; Zupi G; Floridi A
Oncol Res; 1996; 8(3):111-20. PubMed ID: 8823807
[TBL] [Abstract][Full Text] [Related]
10. The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routes.
Davidescu M; Macchioni L; Scaramozzino G; Cristina Marchetti M; Migliorati G; Vitale R; Corcelli A; Roberti R; Castigli E; Corazzi L
Sci Rep; 2015 Sep; 5():14343. PubMed ID: 26387611
[TBL] [Abstract][Full Text] [Related]
11. Diazepam enhances hypericin-induced photocytotoxicity and apoptosis in human glioblastoma cells.
Sarissky M; Lavicka J; Kocanová S; Sulla I; Mirossay A; Miskovsky P; Gajdos M; Mojzis J; Mirossay L
Neoplasma; 2005; 52(4):352-9. PubMed ID: 16059654
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of lonidamine combined with different DNA-damaging agents in the treatment of the MX-1 tumor xenograft.
Pratesi G; De Cesare M; Zunino F
Cancer Chemother Pharmacol; 1996; 38(2):123-8. PubMed ID: 8616901
[TBL] [Abstract][Full Text] [Related]
13. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P
J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902
[TBL] [Abstract][Full Text] [Related]
14. Adaptive mitochondrial reprogramming and resistance to PI3K therapy.
Ghosh JC; Siegelin MD; Vaira V; Faversani A; Tavecchio M; Chae YC; Lisanti S; Rampini P; Giroda M; Caino MC; Seo JH; Kossenkov AV; Michalek RD; Schultz DC; Bosari S; Languino LR; Altieri DC
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25650317
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effect of lonidamine on a human glioblastoma multiforme cell line.
Iacopino F; Sica G; Macrì P; Paggi MG; Scerrati M; Roselli R; Marchetti P; Della Cuna GR; Marini L
J Neurosurg Sci; 1990; 34(3-4):193-7. PubMed ID: 1965900
[TBL] [Abstract][Full Text] [Related]
16. Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells.
Chang CH; Liu WT; Hung HC; Gean CY; Tsai HM; Su CL; Gean PW
BMC Cancer; 2017 Dec; 17(1):905. PubMed ID: 29284440
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines.
Avramis IA; Christodoulopoulos G; Suzuki A; Laug WE; Gonzalez-Gomez I; McNamara G; Sausville EA; Avramis VI
Cancer Chemother Pharmacol; 2002 Dec; 50(6):479-89. PubMed ID: 12451475
[TBL] [Abstract][Full Text] [Related]
18. Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells.
Floridi A; Paggi MG; D'Atri S; De Martino C; Marcante ML; Silvestrini B; Caputo A
Cancer Res; 1981 Nov; 41(11 Pt 1):4661-6. PubMed ID: 7306982
[TBL] [Abstract][Full Text] [Related]
19. Action of the antitumor and antispermatogenic agent lonidamine on electron transport in Ehrlich ascites tumor mitochondria.
Floridi A; Lehninger AL
Arch Biochem Biophys; 1983 Oct; 226(1):73-83. PubMed ID: 6227286
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of cisplatin cytotoxicity by lonidamine in primary cultures of human ovarian cancer.
Orlandi L; Zaffaroni N; Gornati D; Veneroni S; Silvestrini R
Anticancer Res; 1994; 14(3A):1161-4. PubMed ID: 8074467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
